New York State Common Retirement Fund Curis Inc Transaction History

New York State Common Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.71 - $2.43 $43,381 - $148,473	-61,100 Reduced 98.7%	803 $1,000
Q1 2022 May 05, 2022	BUY	$2.31 - $5.13 $154 - $343	67 Added 0.11%	61,903 $147,000
Q4 2021 Feb 02, 2022	SELL	$4.45 - $8.09 $912 - $1,658	-205 Reduced 0.33%	61,836 $294,000
Q3 2021 Nov 02, 2021	SELL	$6.94 - $8.85 $84,383 - $107,607	-12,159 Reduced 16.39%	62,041 $486,000
Q2 2021 Aug 02, 2021	BUY	$7.45 - $16.27 $552,790 - $1.21 Million	74,200 New	74,200 $599,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.